(Press-News.org) SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, unveiled new data today on a novel approach to chronic pain management and joint tissue preservation. The data highlights SN101, a first-in-class induced pluripotent stem cell (iPSC)-derived therapy.
SN101 utilizes mature iPSC-derived peripheral pain-sensing neurons (nociceptors) to treat chronic osteoarthritis joint pain. The data highlights a scientific approach that challenges traditional pain management logic.
“Our approach utilizes high-purity, iPSC-derived nociceptors (SN101) that effectively function as a sponge for pain factors. By injecting SN101 cells, we counterintuitively relieve pain and halt cartilage degradation,” said Gabsang Lee, scientific co-founder of SereNeuro and a professor of neurology and neuroscience at Johns Hopkins University.
SN101 neurons function as a therapeutic sponge by sequestering inflammatory pain factors without transmitting pain signals to the brain. Additionally, the cells secrete mechanistically-confirmed regenerative factors, positioning SN101 as a disease-modifying osteoarthritis drug (DMOAD).
The presentation distinguishes SN101 from emerging single-target therapies, such as Nav 1.8 inhibitors. While ion channel inhibitors are designed to block a solitary pathway, SN101 cells express all canonical pain receptors and ion channels. This biological complexity allows SN101 therapy to inherently operate on all channels simultaneously to downregulate pain and inflammation.
Furthermore, the data contrasts SN101 with current standards, such as corticosteroids.
“Current standard-of-care treatments, particularly corticosteroids, provide temporary relief but are known to accelerate cartilage degradation over time, ultimately worsening the disease,” said Dr. Daniël Saris, a member of SereNeuro’s Clinical Advisory Board and a professor of orthopedics and regenerative medicine at Mayo Clinic.
In contrast to those degenerative effects, SN101 creates an environment that preserves joint tissues and relieves chronic pain, without the risk of addiction.
Presentation Details:
Presenter: Gabsang Lee; Johns Hopkins University, SereNeuro Therapeutics, Inc.; USA
Presentation Title: Rebuilding the Body's Interfaces: Cell Therapy for Neuroskeletal and Surface Tissues
Highlights:
Safety Profile: The use of fully mature, non-dividing cells lowers tumorigenicity risks common in other cell therapies.
Non-Addictive Strategy: A biological alternative to opioids for chronic pain management, directly addressing the need for safer therapeutic options.
DMOAD Potential: Data indicating the halting of cartilage degradation and promotion of healthy bone remodeling, positioning SN101 as a potential disease-modifying osteoarthritis drug (DMOAD), a significant advancement over degenerative corticosteroids.
Date/Time: December 12, 4:15 PM – 4:40 PM
Location: Hyatt Regency Boston Cambridge; 575 Memorial Drive, Cambridge, MA, 02139
About SereNeuro
SereNeuro is a biotechnology company developing first-in-class non-opioid pain therapies. The company is advancing a pipeline of therapies designed to address unmet needs in chronic and neuropathic pain management, moving rapidly toward Investigational New Drug (IND) enabling studies. For more information, visit https://www.sereneuro.com.
About ISSCR
With nearly 5,000 members from more than 80 countries, the International Society for Stem Cell Research is the preeminent global, cross-disciplinary, science-based organization dedicated to stem cell research and its translation to the clinic. The ISSCR mission is to promote excellence in stem cell science and applications to human health.
About the International Symposium
Pluripotent stem cell (PSC)-derived therapies offer transformative potential for hard-to-treat diseases, but their complexity demands a development strategy built around the needs of the final product. The ISSCR's Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind program flips the traditional bench-to-bedside model by starting with the patient and working backwards – ensuring each step supports a safe, effective, and scalable therapy. Global leaders participating in the program are advancing ESC- and iPSC-derived cell therapies as they share insights from cutting-edge clinical trials and the next generation of technologies shaping the future of regenerative medicine.
END
Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain
The announcement was made at the International Society for Stem Cell Research (ISSCR) Symposium Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind
2025-12-12
ELSE PRESS RELEASES FROM THIS DATE:
AI can pick up cultural values by mimicking how kids learn
2025-12-12
Artificial intelligence systems absorb values from their training data. The trouble is that values differ across cultures. So an AI system trained on data from the entire internet won’t work equally well for people from different cultures.
But a new University of Washington study suggests that AI could learn cultural values by observing human behavior. Researchers had AI systems observe people from two cultural groups playing a video game. On average, participants in one group behaved more altruistically. ...
China’s ecological redlines offer fast track to 30 x 30 global conservation goal
2025-12-12
A new commentary in Environmental and Biogeochemical Processes proposes a practical pathway for countries to meet the global goal of protecting 30 percent of land and sea by 2030, known as the 30 × 30 target, by rethinking how existing ecological policies are counted and governed. Focusing on China, the authors argue that the country’s Ecological Protection Redline policy offers a ready model for turning ambitious maps into real conservation outcomes while balancing development needs.
Turning redlines into real protection
China’s Ecological Protection Redline system has legally identified about 32 percent of the ...
Invisible indoor threats: emerging household contaminants and their growing risks to human health
2025-12-12
Indoor dust, air and everyday products are exposing people to a growing mix of “new contaminants” inside homes, schools and workplaces, according to a new perspective published in the journal New Contaminants. The authors warn that these emerging chemicals may quietly increase the risk of heart disease, cancer and developmental problems while remaining largely unregulated and poorly monitored indoors.
Hidden pollution indoors
People now spend about 90 percent of their time indoors, yet most pollution research and standards still focus on outdoor air. The paper highlights that ...
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
2025-12-12
Children with a rare form of cancer called neuroblastoma which hasn’t responded to initial treatment or that has relapsed may benefit from adding antibody treatment to usual chemotherapy, according to new results from a clinical trial.
The results of the BEACON phase 2 trial carried out by an international consortium of researchers, coordinated by the University of Birmingham’s Cancer Research UK Clinical Trials Unit. Published in the Journal of Clinical Oncology found that among children who have a high risk form cancer called neuroblastoma, using a monoclonal antibody treatment called dinutuximab beta ...
Germline pathogenic variants among women without a history of breast cancer
2025-12-12
About The Study: In this secondary analysis of the WISDOM trial, a randomized clinical trial that enrolled women without breast cancer ages 40 to 74, criteria-independent genetic testing in a pragmatic trial identified a substantial number of women with clinically actionable results, many of whom would not have qualified for genetic
testing under current guidelines. These findings support broader access to genetic testing as part of personalized breast cancer risk assessment.
Corresponding Author: To contact the corresponding author, Lisa Madlensky, ...
Tanning beds triple melanoma risk, potentially causing broad DNA damage
2025-12-12
Study analyzed thousands of medical records to compare melanoma rates in tanning bed users vs. non-users, and sequenced 182 skin biopsies from tanning bed users and controls
Tanning bed users carried double the mutation burden of controls
In users, mutations appeared even in body areas that don’t get much sun exposure
CHICAGO ---Tanning bed use is tied to almost a threefold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medicine and University of California, San ...
Unique bond identified as key to viral infection speed
2025-12-12
UNIVERSITY PARK, Pa. — Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research led by scientists at Penn State reveals a deliberate imbalance in their shape that helps them infect their hosts.
The finding, the researchers say, not only illuminates a fundamental viral strategy but also opens doors for antiviral drug design and molecular delivery technologies critical for vaccines, cancer therapies, medication development and ...
Indoor tanning makes youthful skin much older on a genetic level
2025-12-12
Tanning bed users are known to have a higher risk of skin cancer, but for the first time researchers have found that young indoor tanners undergo genetic changes that can lead to more mutations in their skin cells than people twice their age.
The study, which was led by UC San Francisco and Northwestern University, appears Dec. 12 in Science Advances.
“We found that tanning bed users in their 30s and 40s had even more mutations than people in the general population who were in their 70s and ...
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
2025-12-12
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also affects other organs, including the brain, heart and gastrointestinal (GI) tract. Although around 80% of people with DM1 experience GI problems that greatly reduce their quality of life, including difficulty swallowing, delayed stomach emptying, constipation and severe conditions like intestinal obstruction, the underlying causes remain understudied.
To shed light onto the causes and potential solutions to ...
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
2025-12-12
Reston, VA (December 12, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
Tracking Kidney Cancer Spread with a New Targeted Imaging Tool
This study explored whether two biomarkers—CD70 ...
LAST 30 PRESS RELEASES:
Low-temperature-activated deployment of smart 4D-printed vascular stents
Clinical relevance of brain functional connectome uniqueness in major depressive disorder
For dementia patients, easy access to experts may help the most
YouTubers love wildlife, but commenters aren't calling for conservation action
New study: Immune cells linked to Epstein-Barr virus may play a role in MS
AI tool predicts brain age, cancer survival, and other disease signals from unlabeled brain MRIs
Peak mental sharpness could be like getting in an extra 40 minutes of work per day, study finds
No association between COVID-vaccine and decrease in childbirth
AI enabled stethoscope demonstrated to be twice as efficient at detecting valvular heart disease in the clinic
Development by Graz University of Technology to reduce disruptions in the railway network
Large study shows scaling startups risk increasing gender gaps
Scientists find a black hole spewing more energy than the Death Star
A rapid evolutionary process provides Sudanese Copts with resistance to malaria
Humidity-resistant hydrogen sensor can improve safety in large-scale clean energy
Breathing in the past: How museums can use biomolecular archaeology to bring ancient scents to life
Dementia research must include voices of those with lived experience
Natto your average food
Family dinners may reduce substance-use risk for many adolescents
Kumamoto University Professor Kazuya Yamagata receives 2025 Erwin von Bälz Prize (Second Prize)
Sustainable electrosynthesis of ethylamine at an industrial scale
A mint idea becomes a game changer for medical devices
Innovation at a crossroads: Virginia Tech scientist calls for balance between research integrity and commercialization
Tropical peatlands are a major source of greenhouse gas emissions
From cytoplasm to nucleus: A new workflow to improve gene therapy odds
Three Illinois Tech engineering professors named IEEE fellows
Five mutational “fingerprints” could help predict how visible tumours are to the immune system
Rates of autism in girls and boys may be more equal than previously thought
Testing menstrual blood for HPV could be “robust alternative” to cervical screening
Are returning Pumas putting Patagonian Penguins at risk? New study reveals the likelihood
Exposure to burn injuries played key role in shaping human evolution, study suggests
[Press-News.org] Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic painThe announcement was made at the International Society for Stem Cell Research (ISSCR) Symposium Accelerating PSC-Derived Cell Therapies: Starting with the End in Mind